Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
NCT06779929 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70000
Last updated 2026-05-15
Summary
This cohort study was initiated to emulate the design of the SURPASS-CVOT trial using observational analogues of the trial design components in a study based on insurance claims data.
Conditions
Interventions
- DRUG
-
Tirzepatide
- DRUG
-
Dulaglutide
- DRUG
-
Semaglutide
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-01
- Primary Completion
- 2025-12-01
- Completion
- 2026-03-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
NCT05963022 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
NCT06914895 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
NCT05822830 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
NCT06047548 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
NCT07247084 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
NCT03861052 ·Status: COMPLETED ·Phase: PHASE3
-
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
NCT06180616 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)
NCT05024032 ·Status: COMPLETED ·Phase: PHASE3
-
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
NCT06962280 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
NCT06914141 ·Status: COMPLETED
-
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
NCT04184622 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program
NCT04657016 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
NCT06037252 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
NCT06066528 ·Status: COMPLETED ·Phase: PHASE3
-
Tirzepatide Use in People With Obesity and Type 1 Diabetes
NCT07096908 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
NCT06373146 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
NCT06439277 ·Status: RECRUITING ·Phase: PHASE3
-
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
NCT06326060 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tirzepatide for Weight Management
NCT06918405 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
NCT02963922 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
NCT06603571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide
NCT04407234 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
NCT07099742 ·Status: NOT_YET_RECRUITING
-
A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease
NCT04844918 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
NCT06066515 ·Status: COMPLETED ·Phase: PHASE3